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INTRODUCTION
The incorporation of halogenated pyrimidines (HPs) is known to increase the radiosensitivity of mammalian cells in vitro and in vivo. The HPs bromo-deoxyuridine ( BrdUrd) and iodo-deoxyuridine ( IdUrd) are already applied clinically to enhance loco-regional effectiveness (8, 28, 31, 35) . The level of radiosensitization by HPs has been shown to correlate with the degree of thymidine replacement (6, 16, 27, 32) . However, in recent reports it has been argued that the fraction of labeled cells in tumors may be too low for a significant clinical success of HPinduced radiosensitization, although the level of thymidine replacement by HPs in proliferating tumor cells would allow more sensitization (7, 30) . The optimal administration schedule for HPs is still a matter of debate (7, 16, 35) .
Hyperthetmia (HT) is also known to sensitize cells to radiation and has recently been shown to be beneficial in combination with radiotherapy (9, 25 1. It has been reported that HT can block the repair of DNA double-strand breaks (23), which are supposed to be the lesions by which radiation kills cells (26) . The incorporation of HPs have been shown to increase the amount of radiationinduced DNA double-strand breaks ( 14, 38. 39) .
The influence of modifying agents on radiation survival curves of mammalian cells is analyzed increasingly in terms of changes in the parameters derived from the description of the shapes of these curves according to the linear-quadratic model (LQ) (17, (20) (21) (22) . This model has been found to describe the low-dose region of the curves better than the single-hit multitarget model (2,33 >. The LQ model leads to a description of survival curves by the formula: S(D)/S(O) = exp -(aD + PD'). Using this model, more insight can be obtained into the quantitative aspects of the sensitization of tumors and their constituent cells by a combination of HT and incorporation Reprint requests to: Chris van Bree, Academic Medical Center,490 I. J. Radiation Oncology 0 Biology 0 Physics I of HPs, especially in the dose range of 1 to 3 Gy, as commonly applied in fractionated radiotherapy.
Several groups have studied the effect of HPs on radiosensitization in human cancer cell lines of different radiosensitivities (16, 17, (20) (21) (22) 34) . In studies of the radiosensitization of human colon cancer cell lines by incorporation of the IdUrd and BrdUrd, it has been shown that the linear term in the LQ formula, which dominates the response at low doses, is strongly increased, but that the quadratic term is hardly affected (17, (20) (21) (22) . In otherwise untreated cells, it has been reported that HT increased the quadratic parameter and to a lesser extent also the linear parameter ( 10). Previous reports of studies on the radiosensitivity of cultured Chinese hamster cells, in which effects of I-IT and incorporation of HPs in DNA were measured, did not incorporate an analysis in terms of the LQ model, but changes were evaluated in terms of a final slope and extrapolation number of survival curves (29) .
To study the possible improvement of the efficacy of HP-induced radiosensitization, we performed experiments on the effectiveness of radiosensitization by HPs in combination with HT. In the present report, we compare the effects of HPs and HT and study the combination of these treatments for tumor cells in vitro. It is generally recognized that the effectiveness of fractionated radiotherapy with dose fractions of 2 Gy is largely determined by the linear parameter of the LQ formula. Because cells with a small linear parameter respond poorly to fractionated radiotherapy, we selected two tumor cell lines of different radiosensitivities that can be analyzed quantitatively in vitro and that can be transplanted into rats for future in vivo studies (36, 37) . We extended the investigations with a murine and a human tumor cell line and with Chinese hamster lung fibroblasts to assess a wide range of linear and quadratic parameters.
MATERIALS AND METHODS

Cell culture
Cultures of cells from a rat R-l rhabdomyosarcoma, a rat RUC-II urether carcinoma, a murine MOS osteosarcoma, a human SW1573 lung carcinoma, and Chinese hamster V79 lung fibroblasts were used. Cell cycle times were lo-12 h for RUC-II, MOS, and V79 cells, 14-16 h for R-l cells, and 20-23 h for SW1573 cells (1, 11, 15) . Cells were grown as monolayers in tissue culture flasks' (75 cm*) in the appropriate growth medium (rodent cells in minimal essential medium* in an atmosphere of 2% CO2 in air, human cells in Leibovitz-15 medium* in air, both supplemented with 10% fetal bovine serum, glutamine, and penicillin at 37°C). All cell lines were passaged twice a week at moderate den- Volume 39, Number 2, 1997 sity (l-2 x lo5 cells per flask) to maintain exponential growth. For experiments, the cells were plated at low density (2-5 X lo4 cells per flask) to ensure that the cells were growing exponentially during the entire drug exposure interval. The rodent cells were incubated for 72 h in 10 ml MBMs in the presence of 1, 2, and 4 PM of chloro-deoxyuridine (CldUrd), BrdUrd, or IdUrd? The human cells were incubated for 96 h because of their longer cell cycle time. The highest HP concentrations did not significantly slow down cell proliferation, and flow cytometry studies showed that no cell cycle redistribution occurred (data not shown). In rodent cells, thymidine was added at a concentration of 2.5 PM to mimic the average level of thymidine in rodent plasma (30) .
Incorporation of HPs
Thymidine replacement was measured by the technique described by Miller et al. (21) . In short, cells were plated at a cell density of 0.5 -1 X lo5 per flask and treated with CldUrd, BrdUrd, and IdUrd, as described above. Cells were trypsinized, pelleted, and lysed in water. After isolation from the lysate, DNA was digested to liberate nucleosides. The digest was analyzed by high-pressure liquid chromatography. Percentage thymidine replacement was calculated as the concentration of incorporated HP X 100 divided by the sum of the concentrations thymidine and incorporated HP. Recovery differences between samples were monitored by comparison of the concentration of guanidine divided by the sum of the concentrations of thymidine and incorporated HP.
Irradiation and hyperthermia
For the assessment of radiation survival after exposure to CldUrd, BrdUrd, or IdUrd, the cells were trypsinized and plated in appropriate dilutions in growth medium in six-well macroplates. Four hours after plating, the cells were irradiated with gamma-rays from a 137Cs source, yielding a dose rate of about 1 Gy/min. For HT, the macroplates were placed immediately after irradiation in a thermostatically regulated waterbath for 60 min at 42.O"C.
Analysis and statistics
Following irradiation and/or I-IT, the cells were incubated for 5-7 days without changing the culture medium. Subsequently, the colonies were fixated with 100% ethanol and stained with 10% Giemsa. Colonies of 50 cells or more were scored as originating from a single clonogenic cell. Surviving fractions were calculated and analyses were performed by fitting the survival curves according to the LQ formula using statistical software5 performing a fit to the data by multiple regression. Statistical analyses were performed with statistical software using the twosided Student's t-test.
' Costar Europe Ltd., Badhoevedorp, The Netherlands. 
RESULTS
Radiation dose-survival curves of the radiosensitive R-1 and MOS cell lines and the more radioresistant RUC-II and V79 cell lines and the human SW1573 cell line are shown in Fig. I . The linear term determining the initial slope (a-parameter) and the quadratic term determining the continuously curving high dose region (p-parameter) of the radiation survival curves of these cell lines are presented in Table 1 and are shown to differ considerably. The exposure to HPs at the highest concentrations induced a significant reduction in the clonogenic capacity compared to the control. Most toxicity was observed with BrdUrd in the more radiosensitive cell lines (up to 90% cell kill, data not shown). Surviving fractions after irradiation were always corrected for any decrease in plating efficiency.
As shown in Fig. 2 , the exposure to the highest concentration of CldUrd and BrdUrd resulted in a significant reduction in the surviving fraction after HT alone in all cell lines. For IdUrd, a significantly enhanced thermal sensitivity was observed in the RUC-II, MOS, and SW1573 cell lines.
Examples of radiation dose-survival curves of R-l and RUC-II ceils after exposure to the highest HP concentration with and without HT are shown in Fig. 3 . The exposure of HPs resulted in radiosensitization that depends on HP concentration in the medium (data not shown). Treatment with HT of irradiated cells, which had incorporated HPs, resulted in a further decrease in surviving fraction in all cell lines, independent of the HP used.
Linear-quadratic analysis of the radiation dose -survival curves showed that the treatment with HT and HPs significantly increased the a-parameter of all cell lines (see Table 2 for the data on R-l and RUC-II cells). In Linear correlations were derived between the a-parameter and thymidine replacement. At equal levels of thymidine replacement, IdUrd was found to be the most potent radiosensitizer, followed by BrdUrd and CldUrd. It could also be deduced that the a-value of the radioresistant RUC-II cells was increased by multiplication factors in excess of 50. Furthermore, it was observed that HT and HPs did not change the p-parameter by as large a factor. As a consequence, the alp ratio for all cell lines increased (see Table 2 for the data on R-l and RUC-II cells). An overview of the changes in the a-parameter induced by the most potent radiosensitizer, IdUrd, and HT is shown in Fig. 5 . The combination of IdUrd and HT resulted in a marked increase in all cell lines. The relative increase in the linear parameter, i.e., values without HP incorporation, were taken as unity, indicated that HPs caused an increase in the range of 2-5 at the highest thymidine replacement, while HT alone increased the a-parameter two-to fourfold (data not shown). Comparison of the results on the relative increase in the linear parameter after treatment with the combination of IdUrd and HT indicated that the values obtained after single treatments were approximately additive.
DISCUSSION
The in vitro experiments reported in this study were aimed at investigating the possible influence of HT in combination with radiosensitization by HPs. In our initial experiments, we measured HP-induced radiosensitization to compare with published data. Our data confirm that the level of radiosensitization by incorporation of CldUrd, BrdUrd, and IdUrd is directly correlated with the degree of thymidine replacement (6, 16, 27, 32) .
In our studies, it was also found that the incorporation of CldUrd and BrdUrd plateaued at 30 to 35% of thymidine replacement ( 16). The incorporation of IdUrd into DNA was lower in all cell lines. It has been reported that human colon cancer cells in a murine xenograft model incorporated less IdUrd as expected from in vitro data (30) . Because IdUrd incorporation is probably lowered by endogenous plasma thymidine concentration, which in rodents is much higher than in humans (24), thymidine was added to the culture medium of rodent cell lines to mimic the plasma thymidine levels. On the other hand, our data demonstrate that without additional thymidine IdUrd incorporation in SW1573 cells was significantly lower than CldUrd and BrdUrd (data not shown).
Our results furthermore confirm that IdUrd is the most potent radiosensitizer, related to the larger size of I in comparison with Br and Cl (5, 21, 22) .
Although higher thymidine replacement would result in more radiosensitization, the incorporation of IdUrd in the cell lines studied was similar to the levels presently achieved in the clinic. The observed thymidine replacement already showed significant radiosensitization. Because IdUrd is also preferred over BrdUrd in the clinic because of its reduced toxicity with or without hyperthermia (60 min at 42°C). Mean values with standard error of the mean of at least three separate experiments are plotted. Lines represent polynomial fits to the data. radioresistant cells more. The observation that treatment with HPs and HT of radioresisrant RUC-II cells leads to multiplication factors of the a-parameter in excess of 50 suggests that the combined treatment is very promising for highly radioresistant tumors. As suggested earlier (21, 22), changes in the low dose region relevant to clinical radiotherapy can be analyzed in terms of the sensitizer enhancement ratio at 2 Gy (SER 2 Gy). The changes in the SER 2 Gy induced by various treatments were found to be similar to the changes in the relative increase in the a-parameter (data not shown), indicating that the SER 2 Gy is dominated by the a-parameter of the LQ formalism. When the data on the relative increase in the a-parameter were corrected for the radiosensitizing effect of HT alone, no significant changes in the extent of HP-induced radiosensitization was observed. It has been shown in Chinese hamster V79 cells that BrdUrd and IdUrd incorporation did not alter the sensitivity to a heat dose of 45°C for 5 min (29) . Our data support the suggestion that the mechanisms of radiosensitization by HT and incorporation of HPs are not the same (29) . perthermia (60 min at 42°C) was combined with exposure to 4 PM CldUrd, BrdUrd, or IdUrd, and its effect is indicated by arrows. Mean values with standard errors of the mean for at least three separate experiments are plotted. Lines represent linear fits to the data for CldUrd (solid line), BrdUrd (dotted line), and IdUrd (dashed line).
Nonetheless, it is evident that both treatments do not antagonize and, therefore, the combination might be useful in clinical application.
In summary, our findings indicate that HT in combination with the incorporation of HPs additively increases the radiosensitivity of the exponentially growing rodent as well as of human tumor cell lines, reflected by an increase in the linear parameter of the LQ model. In particular, in a cell line with a very low a-value, a large radio-1.
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13. sensitization factor was obtained. The increasing values of the ratio alp with increasing sensitization imply that, especially in HP-sensitized cells, the contribution of the quadratic parameter is relatively small, and fractionation effects are expected to be small in the dose range of 1 to
